INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 440m ago
House PTR40m ago
SEC 13F40m ago
Robinhood Chain40m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Oct 16, 2026Oct 20, 2026
Page 152 of 1649
← PrevNext →
traded Oct 16, 2026
+4d
SEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,889 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,473 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
351 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
885 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
351 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,416 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,889 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$50K
710 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$12K
176 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

5
VM
VanHimbergen Robert MEVP and CFO
ELANElanco Animal Health Inc
Grant or award
A$197
8 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

2
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Option exercise
M—
1,021 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

2
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Option exercise
M—
1,021 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

0
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise · 10b5-1 plan
M—
4,400 sh
Oct 17, 2026Oct 20, 2026
traded Oct 17, 2026
+3dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
5,572 sh
Oct 20, 2026Oct 20, 2026
traded Oct 20, 2026
+0dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
5,572 sh
Oct 20, 2026Oct 20, 2026
traded Oct 20, 2026
+0dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
5,572 sh
Oct 20, 2026Oct 20, 2026
traded Oct 20, 2026
+0dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
2,724 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Other acquisition or disposition · 10b5-1 plan
J—
2,724 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

0
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise · 10b5-1 plan
M—
4,400 sh
Oct 17, 2026Oct 20, 2026
traded Oct 17, 2026
+3dSEC Form 4

Evidence

0
HE
Hafer EvanDirector, Founder, 10% Owner
BRCCBRC Inc.
Derivative conversion · 10b5-1 plan
C—
2,724 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC Form 4

Evidence

56
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market purchase
BUY$2,186
23 sh
Jul 8, 2026Oct 19, 2026
traded Jul 8, 2026
+103dSEC Form 4

Evidence

49
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Open-market purchase
BUY$11.50M
718.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

42
ZG
Zhang Jason GechenPresident
APLDApplied Digital Corp.
Open-market purchase
BUY$5.66M
300.0K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

36
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market sale
SELL$1,905
23 sh
Apr 22, 2026Oct 19, 2026
traded Apr 22, 2026
+180dSEC Form 4

Evidence

35
PS
Purcell Lynn SebastianDirector, 10% Owner
CNXUConexeu Sciences Inc.
Open-market purchase
BUY$500K
166.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

35
RV
Radakovich Lynn VojvodichDirector
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$381K
16.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

33
PS
Purcell Lynn SebastianDirector, 10% Owner
CNXUConexeu Sciences Inc.
Open-market purchase
BUY—
166.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

33
CP
Carlson Michael PaulGENERAL COUNSEL & SECRETARY
NONENONESterling Real Estate Trust
Open-market purchase
BUY$2,000
78 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

32
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market sale
SELL$11K
108 sh
Aug 24, 2026Oct 19, 2026
traded Aug 24, 2026
+56dSEC Form 4

Evidence

31
BM
Buckley MerileeCHIEF ACCOUNTING OFFICER
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$457K
5,076 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$535K
2,700 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$312K
1,600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$697K
3,500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$841K
4,200 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$470K
2,400 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

28
RV
Radakovich Lynn VojvodichDirector
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
3,500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

27
AJ
Aballi JohnDirector, President and CEO
XGNEXAGEN INC.
Open-market sale
SELL$270K
34.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

26
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$116K
600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence